114 related articles for article (PubMed ID: 8648366)
1. Expression of a CD44 variant containing exons 8 to 10 is a useful independent factor for the prediction of prognosis in colorectal cancer patients.
Yamaguchi A; Urano T; Goi T; Saito M; Takeuchi K; Hirose K; Nakagawara G; Shiku H; Furukawa K
J Clin Oncol; 1996 Apr; 14(4):1122-7. PubMed ID: 8648366
[TBL] [Abstract][Full Text] [Related]
2. [Expression of variant CD44 in colorectal cancer and its relationship to liver metastasis].
Yamaguchi A
Nihon Geka Gakkai Zasshi; 1998 Jul; 99(7):409-14. PubMed ID: 9742519
[TBL] [Abstract][Full Text] [Related]
3. Clinical significance of combined immunohistochemical detection of CD44v and sialyl LeX expression for colorectal cancer patients undergoing curative resection.
Yamaguchi A; Goi T; Seki K; Ohtaki N; Maehara M; Kobayashi T; Niimoto S; Katayama K; Hirose K; Nakagawara G; Matsukawa S
Oncology; 1998; 55(5):400-3. PubMed ID: 9732216
[TBL] [Abstract][Full Text] [Related]
4. Clinical significance of serum levels of CD44 variant exons 8-10 protein in colorectal cancer.
Yamaguchi A; Goi T; Taguchi S; Ohtaki N; Seki K; Hirose K; Nakagawara G; Urano T; Furukawa K
J Gastroenterol; 1998 Jun; 33(3):349-53. PubMed ID: 9658313
[TBL] [Abstract][Full Text] [Related]
5. Expression of variant CD44 containing variant exon v8-10 in gallbladder cancer.
Yamaguchi A; Zhang M; Goi T; Fujita T; Niimoto S; Katayama K; Hirose K
Oncol Rep; 2000; 7(3):541-4. PubMed ID: 10767365
[TBL] [Abstract][Full Text] [Related]
6. Expression of CD44 variant exons 8-10 in gastric cancer.
Yamaguchi A; Saito M; Gio T; Iida A; Takeuchi K; Hirose K; Nakagawara G; Urano T; Furukawa K; Shiku H
Jpn J Cancer Res; 1995 Dec; 86(12):1166-71. PubMed ID: 8636005
[TBL] [Abstract][Full Text] [Related]
7. Over expression of CD44V8-10 in urinary exfoliated cells as an independent prognostic predictor in patients with urothelial cancer.
Miyake H; Eto H; Arakawa S; Kamidono S; Hara I
J Urol; 2002 Mar; 167(3):1282-7. PubMed ID: 11832714
[TBL] [Abstract][Full Text] [Related]
8. CD44 with variant exons 8-10 in colorectal tumors.
Goi T; Yamaguchi A; Takeuchi K; Nakagawa G; Yamashiro S; Furukawa K; Urano T; Shiku H
Int J Oncol; 1996 Apr; 8(4):657-62. PubMed ID: 21544409
[TBL] [Abstract][Full Text] [Related]
9. Heparanase expression in human colorectal cancer and its relationship to tumor angiogenesis, hematogenous metastasis, and prognosis.
Sato T; Yamaguchi A; Goi T; Hirono Y; Takeuchi K; Katayama K; Matsukawa S
J Surg Oncol; 2004 Sep; 87(4):174-81. PubMed ID: 15334632
[TBL] [Abstract][Full Text] [Related]
10. CD44 Splice Variant v8-10 as a Marker of Serous Ovarian Cancer Prognosis.
Sosulski A; Horn H; Zhang L; Coletti C; Vathipadiekal V; Castro CM; Birrer MJ; Nagano O; Saya H; Lage K; Donahoe PK; Pépin D
PLoS One; 2016; 11(6):e0156595. PubMed ID: 27253518
[TBL] [Abstract][Full Text] [Related]
11. Soluble CD44 variant 6 as a prognostic indicator in patients with colorectal cancer.
Yamane N; Tsujitani S; Makino M; Maeta M; Kaibara N
Oncology; 1999 Apr; 56(3):232-8. PubMed ID: 10202279
[TBL] [Abstract][Full Text] [Related]
12. Expression of CD44 variant exon 6 in stage I non-small cell lung carcinoma as a prognostic factor.
Hirata T; Fukuse T; Naiki H; Hitomi S; Wada H
Cancer Res; 1998 Mar; 58(6):1108-10. PubMed ID: 9515789
[TBL] [Abstract][Full Text] [Related]
13. Prognostic value of CD44 expression in colorectal carcinomas.
Sökmen S; Lebe B; Sarioglu S; Füzün M; Terzi C; Küpelioglu A; Ellidokuz H
Anticancer Res; 2001; 21(6A):4121-6. PubMed ID: 11911305
[TBL] [Abstract][Full Text] [Related]
14. Expression of DCC protein in colorectal tumors and its relationship to tumor progression and metastasis.
Saito M; Yamaguchi A; Goi T; Tsuchiyama T; Nakagawara G; Urano T; Shiku H; Furukawa K
Oncology; 1999; 56(2):134-41. PubMed ID: 9949300
[TBL] [Abstract][Full Text] [Related]
15. CD44v8-10 is a cancer-specific marker for gastric cancer stem cells.
Lau WM; Teng E; Chong HS; Lopez KA; Tay AY; Salto-Tellez M; Shabbir A; So JB; Chan SL
Cancer Res; 2014 May; 74(9):2630-41. PubMed ID: 24618343
[TBL] [Abstract][Full Text] [Related]
16. Prognostic role of p53 messenger ribonucleic acid expression in patients after curative resection for stage I to III colorectal cancer: association with colon cancer stem cell markers.
Huh JW; Kim HR; Kim YJ
J Am Coll Surg; 2013 Jun; 216(6):1063-9. PubMed ID: 23571142
[TBL] [Abstract][Full Text] [Related]
17. Prokineticin 1 protein expression is a useful new prognostic factor for human sporadic colorectal cancer.
Nakazawa T; Goi T; Hirono Y; Yamaguchi A
Ann Surg Oncol; 2015 May; 22(5):1496-503. PubMed ID: 25331005
[TBL] [Abstract][Full Text] [Related]
18. [Immunohistochemical detection of p53 in colorectal cancer and its relationship to prognosis].
Yamaguchi A; Fushida S; Kurosaka Y; Kanno M; Yonemura Y; Miyazaki I
Nihon Geka Gakkai Zasshi; 1992 Oct; 93(10):1312-6. PubMed ID: 1435694
[TBL] [Abstract][Full Text] [Related]
19. Prognostic significance of cytokeratin-20 reverse transcriptase polymerase chain reaction in lymph nodes of node-negative colorectal cancer patients.
Rosenberg R; Hoos A; Mueller J; Baier P; Stricker D; Werner M; Nekarda H; Siewert JR
J Clin Oncol; 2002 Feb; 20(4):1049-55. PubMed ID: 11844829
[TBL] [Abstract][Full Text] [Related]
20. Variant isoforms of CD44 involves acquisition of chemoresistance to cisplatin and has potential as a novel indicator for identifying a cisplatin-resistant population in urothelial cancer.
Hagiwara M; Kikuchi E; Tanaka N; Kosaka T; Mikami S; Saya H; Oya M
BMC Cancer; 2018 Jan; 18(1):113. PubMed ID: 29385995
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
